OR WAIT null SECS
February 15, 2024
Scientists develop algorithms that can not only identify tumors that will respond well to chemotherapy, but which are also likely to resist treatment.
February 13, 2024
The analysis notes that 60% of respondents were setting targets based on AI’s ability to either cut costs or boost productivity.
In this video interview with Associate Editor Miranda Schmalfuhs, Dr. Jo Varshney, CEO & Founder of VeriSIMLife, discusses how artificial intelligence and machine learning can assist in the drug shortage problem.
February 07, 2024
The era of big pharma as product-first companies must end, as services become the larger priority.
January 25, 2024
As technology continues to advance, investigators explore the legal protocol for how to handle AI-responsible injuries.
January 24, 2024
Offerings include treatment plans for a considerable number of illnesses and conditions, company says.
January 23, 2024
Study describes how a game theoretic model can successfully analyze how adoption of blockchain technology can reveal quality information.
January 22, 2024
A discussion of where cell and gene therapies are currently doing, what's on the horizon, personalization, and much more.
January 18, 2024
The predicted value is largely driven by manufacturers' prioritization of brand protection.
Bloomlife’s MFM-Pro enables healthcare providers to measure maternal and fetal heart rate in the patient's home or clinic.